(Z)-2-[[1-(4-chlorophenyl)-5-oxo-3-propyl-4H-pyrazol-4-yl]methyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enoic acid

C23H20ClF3N2O3 — CID 6368346

IUPAC(Z)-2-[[1-(4-chlorophenyl)-5-oxo-3-propyl-4H-pyrazol-4-yl]methyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enoic acid
SMILESCCCC1=NN(c2ccc(Cl)cc2)C(=O)C1C/C(=C/c1ccc(C(F)(F)F)cc1)C(=O)O
InChIInChI=1S/C23H20ClF3N2O3/c1-2-3-20-19(21(30)29(28-20)18-10-8-17(24)9-11-18)13-15(22(31)32)12-14-4-6-16(7-5-14)23(25,26)27/h4-12,19H,2-3,13H2,1H3,(H,31,32)/b15-12-
InChIKeyYOONLOIGFQVUOP-QINSGFPZSA-N
MW464.87 g/mol
LogP6.04
Rot. Bonds7

About (Z)-2-[[1-(4-chlorophenyl)-5-oxo-3-propyl-4H-pyrazol-4-yl]methyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enoic acid

(Z)-2-[[1-(4-chlorophenyl)-5-oxo-3-propyl-4H-pyrazol-4-yl]methyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enoic acid (PubChem CID 6368346) has the molecular formula C23H20ClF3N2O3 and a molecular weight of 464.87 g/mol. Its IUPAC name is (Z)-2-[[1-(4-chlorophenyl)-5-oxo-3-propyl-4H-pyrazol-4-yl]methyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enoic acid.

Molecular Properties

Compound Name(Z)-2-[[1-(4-chlorophenyl)-5-oxo-3-propyl-4H-pyrazol-4-yl]methyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enoic acid
PubChem CID6368346
Molecular FormulaC23H20ClF3N2O3
Molecular Weight464.87 g/mol
Exact Mass464.11
IUPAC Name(Z)-2-[[1-(4-chlorophenyl)-5-oxo-3-propyl-4H-pyrazol-4-yl]methyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enoic acid
SMILESCCCC1=NN(c2ccc(Cl)cc2)C(=O)C1C/C(=C/c1ccc(C(F)(F)F)cc1)C(=O)O
InChIInChI=1S/C23H20ClF3N2O3/c1-2-3-20-19(21(30)29(28-20)18-10-8-17(24)9-11-18)13-15(22(31)32)12-14-4-6-16(7-5-14)23(25,26)27/h4-12,19H,2-3,13H2,1H3,(H,31,32)/b15-12-
InChIKeyYOONLOIGFQVUOP-QINSGFPZSA-N
XLogP6.04
TPSA69.97 Ų
H-Bond Donors1
H-Bond Acceptors3
Rotatable Bonds7
Heavy Atoms32
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500464.87
LogP ≤ 56.04
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 103

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze (Z)-2-[[1-(4-chlorophenyl)-5-oxo-3-propyl-4H-pyrazol-4-yl]methyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enoic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (Z)-2-[[1-(4-chlorophenyl)-5-oxo-3-propyl-4H-pyrazol-4-yl]methyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enoic acid?
The IUPAC name of (Z)-2-[[1-(4-chlorophenyl)-5-oxo-3-propyl-4H-pyrazol-4-yl]methyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enoic acid (CID 6368346) is (Z)-2-[[1-(4-chlorophenyl)-5-oxo-3-propyl-4H-pyrazol-4-yl]methyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enoic acid.
What is the SMILES notation for (Z)-2-[[1-(4-chlorophenyl)-5-oxo-3-propyl-4H-pyrazol-4-yl]methyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enoic acid?
The canonical SMILES for (Z)-2-[[1-(4-chlorophenyl)-5-oxo-3-propyl-4H-pyrazol-4-yl]methyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enoic acid is CCCC1=NN(c2ccc(Cl)cc2)C(=O)C1C/C(=C/c1ccc(C(F)(F)F)cc1)C(=O)O.
What is the InChIKey of (Z)-2-[[1-(4-chlorophenyl)-5-oxo-3-propyl-4H-pyrazol-4-yl]methyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enoic acid?
The InChIKey is YOONLOIGFQVUOP-QINSGFPZSA-N. The full InChI is InChI=1S/C23H20ClF3N2O3/c1-2-3-20-19(21(30)29(28-20)18-10-8-17(24)9-11-18)13-15(22(31)32)12-14-4-6-16(7-5-14)23(25,26)27/h4-12,19H,2-3,13H2,1H3,(H,31,32)/b15-12-.
What are the key properties of (Z)-2-[[1-(4-chlorophenyl)-5-oxo-3-propyl-4H-pyrazol-4-yl]methyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enoic acid?
(Z)-2-[[1-(4-chlorophenyl)-5-oxo-3-propyl-4H-pyrazol-4-yl]methyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enoic acid has a molecular weight of 464.87 g/mol, XLogP of 6.04, 7 rotatable bonds, 1 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for (Z)-2-[[1-(4-chlorophenyl)-5-oxo-3-propyl-4H-pyrazol-4-yl]methyl]-3-[4-(trifluoromethyl)phenyl]prop-2-enoic acid is sourced from PubChem (CID 6368346), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).